- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05182827
Affective Touch, Hedonia and Suicidal Behavior (TOUCH-S)
Several elements suggest that suicidal vulnerability may be associated with an alteration in the perception of affective touch. On the one hand, anhedonia, characterized by a decrease in the pleasure felt, is strongly associated with suicidal ideation, independently of depression. However, the ability to feel pleasure is essential in the perception of affective touch. On the other hand, suicidal behaviors are associated with interpersonal difficulties, of which communication is an integral part, and communication is partly through touch.
The investigators therefore wish to explore the perception of affective touch in suicidal behavior by using an affective tactile stimulation in 72 subjects with and without a history of suicide attempts (SA).
Study Overview
Status
Intervention / Treatment
Detailed Description
This study aims to compare the perceived hedonic nature of affective touch in euthymic subjects with a history of SA and euthymic subjects without a history of SA.
The investigators also aim to :
- compare the perceived hedonic nature of non-affective touch in this population;
- compare the perceived intensity of affective touch;
- compare the perceived intensity of non-affective touch;
- study the association between decision making performance and perceived pleasantness of affective vs. non-affective touch;
- study the association between plasma beta-endorphin levels and the perceived pleasantness of affective vs. non-affective touch;
- study the effect of the tactile stimulation on the expression of opioidergic genes, by comparing the mRNA levels of 6 genes coding for opioidergic receptors and peptides before and after tactile stimulation;
- investigate the association between tactile stimulation-related opioidergic gene expression variation and the perception of the pleasantness of affective versus non-affective touch.
To do so, 72 euthymic women will be included and divided in two groups: 1) Euthymic patients with a lifetime history of major depressive episode and a history of suicidal behavior; 2) Euthymic patients with a lifetime history of a major depressive episode and no history of suicidal behavior.
Participants will be subjected to tactile stimulation (affective and non-affective), following a clinical and neurospychological assessment. During the experimental touch, participants will be asked to evaluate the pleasantness of the touch and its intensity. In addition, blood samples will be taken before and after the stimulation.
Participation will be done in one day or in two visits, up to 72 hours apart.
The investigators expect: 1) subjects with a history of TS to have a decreased perceived pleasantness of affective touch compared to subjects without a history of TS; 2) the difference between the perceived pleasantness of affective versus non-affective touch to be smaller in patients with a history of TS; 3) decision making to be related to the hedonic nature of affective touch; 4) a change in the expression of opioidergic genes.
This study will contribute to a better knowledge of the vulnerability to suicidal behaviors and to a better understanding of psychopathology in order to offer specific and more adapted prevention and management strategies.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- Montpellier University Hospital, France (CHU)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being a woman
- Aged between 18 and 65
- Past major depressive episode according to the DSM-5 criteria
- Currently euthymic (Montgomery-Asberg Depression rating Scale (MADRS) < 12 and Young Mania Rating Scale (YMRS) < 6)
- Minimal psychotropic medication (as determined by the clinician)
- Able to understand experimental procedures
- Able to speak, read and understand French
- Having given written informed consent
- For suicide attempters only: Lifetime history of suicide attempt
- For affective controls only: No lifetime history of suicide attempt
Exclusion Criteria:
- Lifetime diagnosis of schizoaffective disorder, schizophrenia or autism spectrum disorder
- Severe alcohol or substance use disorder in the past 6 months
- Current anorexia nervosa
- Diagnosis of mental retardation or severe medical comorbidity that is unstable or could interfere with measures (HIV, diabetes, cancer, chronic inflammatory disease, neurological disorder, sensory or cognitive disability)
- Injury, scar, irritation/dermatological lesion or tattoo on the left forearm
- Pregnancy or breastfeeding
- Being in exclusion period for another study
- Not being affiliated to the French National Social Security System
- Being deprived of freedom (by judicial or administrative decision)
- Being protected by law (guardianship or curatorship)
- Having reached 4500€ annual compensation for participating to clinical trials
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Euthymic patients with history of suicide attempt (suicide attempters)
Currently euthymic patients with at least one lifetime major depressive episode and a history of suicide attempts
|
The experimental task aims to evaluate the hedonic nature of an affective touch by tactile stimulation. It consists in stimulating two adjacent regions of the left forearm, delimited and marked, of 9 cm x 4 cm each. In order to limit habituation, the stimulation areas will be alternated. To stimulate these areas, the investigator (previously trained) strokes the participant with a brush at an optimal speed to stimulate the C-fibers (3 cm/s; slow speed) or not (18 cm/s; fast speed). Touch will consist of 30 seconds blocks of stimulation, performed on one of the two identified areas, from the elbow to the wrist. In total, 6 stimulation blocks will be done (3 slow and 3 fast), the order and location of which will be random in order to limit habituation. This stimulation is completely painless. After each block, the participant will evaluate the intensity of the stimulation and its pleasantness. |
|
Experimental: Euthymic patients without any history of suicide attempt (affective controls)
Currently euthymic patients with at least one lifetime major depressive episode and with no history of suicide attempts
|
The experimental task aims to evaluate the hedonic nature of an affective touch by tactile stimulation. It consists in stimulating two adjacent regions of the left forearm, delimited and marked, of 9 cm x 4 cm each. In order to limit habituation, the stimulation areas will be alternated. To stimulate these areas, the investigator (previously trained) strokes the participant with a brush at an optimal speed to stimulate the C-fibers (3 cm/s; slow speed) or not (18 cm/s; fast speed). Touch will consist of 30 seconds blocks of stimulation, performed on one of the two identified areas, from the elbow to the wrist. In total, 6 stimulation blocks will be done (3 slow and 3 fast), the order and location of which will be random in order to limit habituation. This stimulation is completely painless. After each block, the participant will evaluate the intensity of the stimulation and its pleasantness. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pleasantness of the touch
Time Frame: at inclusion
|
Perceived pleasantness of the tactile stimulation, assessed with a numeric scale ranging from -5 (very unpleasant) to +5 (very pleasant)
|
at inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intensity of the touch
Time Frame: at inclusion
|
Perceived intensity of the tactile stimulation, assessed with a 10 points Likert scale (low intensity to high intensity).
|
at inclusion
|
|
Decision-making performance (Iowa Gambling Test)
Time Frame: at inclusion
|
Decision-making performance using the IG index from the Iowa Gambling Test (difference between the number of safe and risky choices)
|
at inclusion
|
|
Decision-making performance (Ultimatum Game)
Time Frame: at inclusion
|
Decision-making performance using the UG index from the Ultimatum Game (difference between the number of rejections of unfair and fair offers)
|
at inclusion
|
|
β-endorphin levels
Time Frame: at inclusion
|
Plasmatic levels of β-endorphin
|
at inclusion
|
|
Variation in the expression of opioidergic genes
Time Frame: at inclusion
|
Variation in mRNA levels of 6 genes coding for opioidergic receptors and peptides (OPRM1 (µ), OPRK1 (κ), OPRD1 (δ) and pro-opio-melanocortin, pro-enkephalin, pro-dynomorphin), before and after tactile stimulation
|
at inclusion
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHMPL21_0502
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Episode
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSignature Response to Light Therapy in Unipolar and Bipolar Major Depressive Episode (MDE) (SoLuRep)Major Depressive EpisodeFrance
-
University Hospital, MontpellierRecruitingMajor Depressive EpisodeFrance
-
Medical University of ViennaUnknownMajor Depressive EpisodeAustria
-
The University of New South WalesWesley MissionUnknown
-
Northside Clinic, AustraliaWesley MissionCompletedMajor Depressive EpisodeAustralia
-
Jiangsu Province Nanjing Brain HospitalRecruiting
-
Jiangsu Province Nanjing Brain HospitalCompletedMajor Depressive EpisodeChina
-
Alto NeuroscienceRecruitingBipolar Disorder I or II With a Major Depressive EpisodeUnited States
-
Neumora Therapeutics, Inc.CompletedMajor Depressive Episode Associated With Bipolar II DisorderUnited States
-
Assistance Publique - Hôpitaux de ParisRecruiting
Clinical Trials on Tactile stimulation
-
Leiden University Medical CenterEuropean Society for Paediatric ResearchRecruitingInfant, Premature, Diseases | Birth, PretermDenmark, Norway, Austria, Ireland, Netherlands, Germany, Iceland, Hungary, Portugal, Italy, Poland, Greece, Croatia, Belgium, Czech Republic, Czechia, Romania, Spain, Turkey, Ukraine
-
Virginia Polytechnic Institute and State UniversityRecruiting
-
Peter Tass, MD, PhDTerminatedParkinson DiseaseUnited States
-
University Hospital, GrenobleFaculty of Psychology and Educational Sciences,University of GenevaNot yet recruitingDevelopment, Child | Premature | Rooting ReflexFrance
-
Centre Psychothérapique de NancyRecruiting
-
University of TorontoUnknownPain Management | Healthy Infants | ImmunizationCanada
-
University of Mississippi, OxfordAuburn University; West Virginia University; University of Louisiana at LafayetteWithdrawn
-
King Saud UniversityCompletedHamstring Flexibility
-
University of Geneva, SwitzerlandNot yet recruitingStroke | Body, Foreign